Central Trust CO Corcept Therapeutics Inc Transaction History

Central Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 26, 2019	SELL	$10.03 - $15.71 $6,248 - $9,787	-623 Closed	0 $0
Q4 2018 Jan 08, 2019	SELL	$11.29 - $17.19 $1,016 - $1,547	-90 Reduced 12.62%	623 $8,000
Q3 2018 Oct 04, 2018	BUY	$12.27 - $15.65 $1,349 - $1,721	110 Added 18.24%	713 $0
Q2 2018 Jul 09, 2018	BUY	$15.3 - $19.69 $1,071 - $1,378	70 Added 13.13%	603 $0
Q1 2018 Apr 04, 2018	BUY	$14.59 - $25.5 $7,776 - $13,591	533 New	533 $0

361

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.